Top Markets
Coin of the day
Allgens Medical Technology Co. Ltd. Allgens Medical Technology Co. Ltd.

Allgens Medical Technology Co. Ltd.

688613
Classifica tra le azioni #16116
Allgens Medical Technology Co. Ltd. operates as a medical device firm,... Allgens Medical Technology Co. Ltd. operates as a medical device firm, concentrating on the development and production of sophisticated biomimetic synthetic bone graft systems. These innovative solutions are engineered for global deployment in areas where both cancellous (spongy) and cortical (dense outer layer) bone tissues have been compromised. The company's diverse product portfolio includes key offerings such as BonGold, a mineralized collagen scaffold designed for bone grafting procedures; the high-performance Alligator bone marrow aspirator; and OssaNova, a mineralized collagen-based material utilized for bone filling and augmentation. These products are broadly applied across a spectrum of orthopedic and skeletal repair interventions throughout the human anatomy. Allgens Medical Technology Co. Ltd. was established in 2004 and is headquartered in Beijing, China.
Prezzo delle azioni
$2.28
Capitalizzazione di mercato
$312.51M
Variazione (1 giorno)
0.70%
Variazione (1 anno)
-21.04%
Paese
CN
Scambia Allgens Medical Technology Co. Ltd. (688613)

Categoria

Storico del rendimento da dividendi per Allgens Medical Technology Co. Ltd. (688613)
Il rendimento da dividendi (TTM) di Allgens Medical Technology Co. Ltd. (simbolo azionario: 688613) al 2026 è: 0
Rendimento medio negli ultimi 5 anni: 0.00%
Storico del rendimento da dividendi per Allgens Medical Technology Co. Ltd. (688613) da 2026 a 2026
Rendimento da dividendi alla fine di ogni anno (TTM)
Anno Rendimento da dividendi Cambia
Non abbastanza dati per le date fornite.
Rendimenti da dividendi (TTM) di aziende simili o concorrenti